肝动脉化疗栓塞治疗肝转移癌  

METASTATIC LIVER CANCER TREATED BY TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION

作　　者：许真[1] 严丽[1] 叶本功 寇长元[1] 崔杰[1] 

机构地区：[1]陕西省安康市中心医院肿瘤科,陕西安康725000

出　　处：《河北医科大学学报》2003年第6期348-349,共2页Journal of Hebei Medical University

摘　　要：目的探讨肝转移癌行肝动脉化疗栓塞的疗效。方法运用Seldinger方法对 4 6例肝转移癌行肝动脉栓塞化疗。结果介入治疗后患者症状明显改善、食欲增加、大部分患者瘤体均有不同程度缩小。生存期不超过半年 2例 ,～ 1年 6例 ,～ 2年 2 2例 ,2年以上 16例。不良反应为骨髓抑制、胃肠道反应、发热。结论经肝动脉栓塞化疗是治疗肝转移癌的一种有效疗法 ,不良反应可耐受。ObjectiveThe efficacy of transcatheter arterial chemoembolization (TACE) in the treatment of metastatic liver cancer was studied. MethodsForty-six patients with metartatic liver cancer were treated with TACE by Seldinger procedur. ResultsThe patients'conditions and their appetites were much improved.The tumor size in all cases was reduced at different degrees.Two cases survived nearly half a year,6 cases survived for half to one year,22 cases for one to two years and 16 cases for more than two years.The side-effects included marrow suppression, gastrointestinal reaction and fever. ConclusionThe TACE in the treatment of the metastatic liver cancer is effective and tolerable.

关 键 词：癌 肿瘤转移 肝 肝动脉 药物疗法 联合 

分 类 号：R730.53[医药卫生—肿瘤] R735.7[医药卫生—临床医学]